Robert W. Postma - Nov 29, 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Nov 29, 2022
Transactions value $
$487,500
Form type
4
Date filed
12/1/2022, 03:05 PM
Previous filing
Jun 24, 2022
Next filing
Jun 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $488K +750K +17.65% $0.65 5M Nov 29, 2022 By WaterMill Asset Management Corp. F1, F2
holding TCRT Common Stock 1.24M Nov 29, 2022 Direct F3
holding TCRT Common Stock 3.57K Nov 29, 2022 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp.
F2 The shares were purchased in a registered underwritten offering on November 29, 2022.
F3 Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.